Mitochondrial quality control in the myocardium: Cooperation between protein degradation and mitophagy

Journal of Molecular and Cellular Cardiology

Volumn 75, Issue , 2014, Pages 122-130

  Hammerling, Babette C ^a   Gustafsson, Åsa B ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Aging; Autophagy; Mitochondria; Mitophagy; Parkin; Proteases

Indexed keywords

CELL PROTEIN; MITOCHONDRIAL PROTEIN; PARKIN; PROTEIN PINK1; UNCLASSIFIED DRUG;

AGING; APOPTOSIS; CARDIOMYOPATHY; CELL FUSION; CELL VACUOLE; CHRONIC STRESS; DISORDERS OF MITOCHONDRIAL FUNCTIONS; EXOCYTOSIS; HEART FAILURE; HEART MUSCLE; HUMAN; INNER MITOCHONDRIAL MEMBRANE; INTERMEMBRANE SPACE; MITOCHONDRIAL FISSION; MITOCHONDRIAL MATRIX; MITOCHONDRIAL MEMBRANE; MITOPHAGY; MITOPTOSIS; NONHUMAN; OUTER MITOCHONDRIAL MEMBRANE; PROCEDURES CONCERNING CELLS; PROTEIN DEGRADATION; PROTEIN HOMEOSTASIS; QUALITY CONTROL; REVIEW; ANIMAL; DISEASES; HEART MITOCHONDRION; METABOLISM;

ANIMALS; DISEASE; HUMANS; MITOCHONDRIA, HEART; MITOCHONDRIAL DEGRADATION; MITOCHONDRIAL PROTEINS; MYOCARDIUM; PROTEOLYSIS;

EID: 84916606507     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2014.07.013     Document Type: Review

References (101)

1. Chen Y.R., Zweier J.L. Cardiac mitochondria and reactive oxygen species generation. Circ Res 2014, 114:524-537.
2. Koll H., Guiard B., Rassow J., Ostermann J., Horwich A.L., Neupert W., et al. Antifolding activity of HSP60 couples protein import into the mitochondrial matrix with export to the intermembrane space. Cell 1992, 68:1163-1175.
3. Kang P.J., Ostermann J., Shilling J., Neupert W., Craig E.A., Pfanner N. Requirement for HSP70 in the mitochondrial matrix for translocation and folding of precursor proteins. Nature 1990, 348:137-143.
4. Tarrago L., Kaya A., Weerapana E., Marino S.M., Gladyshev V.N. Methionine sulfoxide reductases preferentially reduce unfolded oxidized proteins and protect cells from oxidative protein unfolding. J Biol Chem 2012, 287:24448-24459.
5. Livnat-Levanon N., Glickman M.H. Ubiquitin-proteasome system and mitochondria - reciprocity. Biochim Biophys Acta 1809, 2011:80-87.
6. Kubli D.A., Gustafsson A.B. Mitochondria and mitophagy: the yin and yang of cell death control. Circ Res 2012, 111:1208-1221.
7. Jeon H.B., Choi E.S., Yoon J.H., Hwang J.H., Chang J.W., Lee E.K., et al. A proteomics approach to identify the ubiquitinated proteins in mouse heart. Biochem Biophys Res Commun 2007, 357:731-736.
8. Kotiadis V.N., Duchen M.R., Osellame L.D. Mitochondrial quality control and communications with the nucleus are important in maintaining mitochondrial function and cell health. Biochim Biophys Acta 1840, 2014:1254-1265.
9. Zhong Q., Gao W., Du F., Wang X. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell 2005, 121:1085-1095.
10. Lokireddy S., Wijesoma I.W., Teng S., Bonala S., Gluckman P.D., McFarlane C., et al. The ubiquitin ligase Mul1 induces mitophagy in skeletal muscle in response to muscle-wasting stimuli. Cell Metab 2012, 16:613-624.
11. Geisler S., Holmstrom K.M., Skujat D., Fiesel F.C., Rothfuss O.C., Kahle P.J., et al. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 2010, 12:119-131.
12. Wang X., Winter D., Ashrafi G., Schlehe J., Wong Y.L., Selkoe D., et al. PINK1 and Parkin target Miro for phosphorylation and degradation to arrest mitochondrial motility. Cell 2011, 147:893-906.
13. Okatsu K., Iemura S., Koyano F., Go E., Kimura M., Natsume T., et al. Mitochondrial hexokinase HKI is a novel substrate of the Parkin ubiquitin ligase. Biochem Biophys Res Commun 2012, 428:197-202.
14. Tanaka A., Cleland M.M., Xu S., Narendra D.P., Suen D.F., Karbowski M., et al. Proteasome and p97 mediate mitophagy and degradation of mitofusins induced by Parkin. J Cell Biol 2010, 191:1367-1380.
15. Ye Y.H., Shibata Y., Kikkert M., van Voorden S., Wiertz E., Rapoport T.A. Recruitment of the p97 ATPase and ubiquitin ligases to the site of retrotranslocation at the endoplasmic reticulum membrane. Proc Natl Acad Sci U S A 2005, 102:14132-14138.
16. Kim N.C., Tresse E., Kolaitis R.M., Molliex A., Thomas R.E., Alami N.H., et al. VCP is essential for mitochondrial quality control by PINK1/Parkin and this function is impaired by VCP mutations. Neuron 2013, 78:65-80.
17. Baker B.M., Haynes C.M. Mitochondrial protein quality control during biogenesis and aging. Trends Biochem Sci 2011, 36:254-261.
18. Hegde R., Srinivasula S.M., Zhang Z., Wassell R., Mukattash R., Cilenti L., et al. Identification of Omi/HtrA2 as a mitochondrial apoptotic serine protease that disrupts inhibitor of apoptosis protein-caspase interaction. J Biol Chem 2002, 277:432-438.
19. Liu H.R., Gao E., Hu A., Tao L., Qu Y., Most P., et al. Role of Omi/HtrA2 in apoptotic cell death after myocardial ischemia and reperfusion. Circulation 2005, 111:90-96.
20. Wang K., Zhang J., Liu J.Y., Tian J., Wu Y., Wang X.L., et al. Variations in the protein level of Omi/HtrA2 in the heart of aged rats may contribute to the increased susceptibility of cardiomyocytes to ischemia/reperfusion injury and cell death. Age 2013, 35:733-746.
21. Martins L.M., Morrison A., Klupsch K., Fedele V., Moisoi N., Teismann P., et al. Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol Cell Biol 2004, 24:9848-9862.
22. Goo H.G., Jung M.K., Han S.S., Rhim H., Kang S. HtrA2/Omi deficiency causes damage and mutation of mitochondrial DNA. Biochim Biophys Acta 1833, 2013:1866-1875.
23. Kang S., Louboutin J.P., Datta P., Landel C.P., Martinez D., Zervos A.S., et al. Loss of HtrA2/Omi activity in non-neuronal tissues of adult mice causes premature aging. Cell Death Differ 2013, 20:259-269.
24. Leonhard K., Guiard B., Pellecchia G., Tzagoloff A., Neupert W., Langer T. Membrane protein degradation by AAA proteases in mitochondria: extraction of substrates from either membrane surface. Mol Cell 2000, 5:629-638.
25. Nolden M., Ehses S., Koppen M., Bernacchia A., Rugarli E.I., Langer T. The m-AAA protease defective in hereditary spastic paraplegia controls ribosome assembly in mitochondria. Cell 2005, 123:277-289.
26. Lau E., Wang D., Zhang J., Yu H., Lam M.P., Liang X., et al. Substrate- and isoform-specific proteome stability in normal and stressed cardiac mitochondria. Circ Res 2012, 110:1174-1178.
27. Bota D.A., Davies K.J. Lon protease preferentially degrades oxidized mitochondrial aconitase by an ATP-stimulated mechanism. Nat Cell Biol 2002, 4:674-680.
28. Bota D.A., Ngo J.K., Davies K.J. Downregulation of the human Lon protease impairs mitochondrial structure and function and causes cell death. Free Radic Biol Med 2005, 38:665-677.
29. Luce K., Osiewacz H.D. Increasing organismal healthspan by enhancing mitochondrial protein quality control. Nat Cell Biol 2009, 11:852-858.
30. Lu B., Yadav S., Shah P.G., Liu T., Tian B., Pukszta S., et al. Roles for the human ATP-dependent Lon protease in mitochondrial DNA maintenance. J Biol Chem 2007, 282:17363-17374.
31. Kang S.G., Dimitrova M.N., Ortega J.Q., Ginsburg A., Maurizi M.R. Human mitochondrial ClpP is a stable heptamer that assembles into a tetradecamer in the presence of ClpX. J Biol Chem 2005, 280:35424-35432.
32. Haynes C.M., Yang Y., Blais S.P., Neubert T.A., Ron D. The matrix peptide exporter HAF-1 signals a mitochondrial UPR by activating the transcription factor ZC376.7 in C. elegans. Mol Cell 2010, 37:529-540.
33. Gispert S., Parganlija D., Klinkenberg M., Drose S., Wittig I., Mittelbronn M., et al. Loss of mitochondrial peptidase Clpp leads to infertility, hearing loss plus growth retardation via accumulation of CLPX, mtDNA and inflammatory factors. Hum Mol Genet 2013, 22:4871-4887.
34. Augustin S., Nolden M., Muller S., Hardt O., Arnold I., Langer T. Characterization of peptides released from mitochondria: evidence for constant proteolysis and peptide efflux. J Biol Chem 2005, 280:2691-2699.
35. Margineantu D.H., Emerson C.B., Diaz D., Hockenbery D.M. HSP90 inhibition decreases mitochondrial protein turnover. PLoS ONE 2007, 2:e1066.
36. Sullivan P.G., Dragicevic N.B., Deng J.H., Bai Y., Dimayuga E., Ding Q., et al. Proteasome inhibition alters neural mitochondrial homeostasis and mitochondria turnover. J Biol Chem 2004, 279:20699-20707.
37. Soubannier V., McLelland G.L., Zunino R., Braschi E., Rippstein P., Fon E.A., et al. A vesicular transport pathway shuttles cargo from mitochondria to lysosomes. Curr Biol 2012, 22:135-141.
38. Soubannier V., Rippstein P., Kaufman B.A., Shoubridge E.A., McBride H.M. Reconstitution of mitochondria derived vesicle formation demonstrates selective enrichment of oxidized cargo. PLoS ONE 2012, 7:e52830.
39. Neuspiel M., Schauss A.C., Braschi E., Zunino R., Rippstein P., Rachubinski R.A., et al. Cargo-selected transport from the mitochondria to peroxisomes is mediated by vesicular carriers. Curr Biol 2008, 18:102-108.
40. McLelland G.L., Soubannier V., Chen C.X., McBride H.M., Fon E.A. Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control. EMBO J 2014, 33:282-295.
41. Levine B., Yuan J. Autophagy in cell death: an innocent convict?. J Clin Invest 2005, 115:2679-2688.
42. Farre J.C., Krick R., Subramani S., Thumm M. Turnover of organelles by autophagy in yeast. Curr Opin Cell Biol 2009, 21:522-530.
43. Jin S.M., Lazarou M., Wang C., Kane L.A., Narendra D.P., Youle R.J. Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J Cell Biol 2010, 191:933-942.
44. Jin S.M., Youle R.J. The accumulation of misfolded proteins in the mitochondrial matrix is sensed by PINK1 to induce PARK2/Parkin-mediated mitophagy of polarized mitochondria. Autophagy 2013, 9:1750-1757.
45. Narendra D., Tanaka A., Suen D.F., Youle R.J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J Cell Biol 2008, 183:795-803.
46. Kim Y., Park J., Kim S., Song S., Won S.K., Lee S.H., et al. PINK1 controls mitochondrial localization of Parkin through direct phosphorylation. Biochem Biophys Res Commun 2008, 377:975-980.
47. Chen Y., Dorn G.W. PINK1-phosphorylated mitofusin 2 is a parkin receptor for culling damaged mitochondria. Science 2013, 340:471-475.
48. Pankiv S., Clausen T.H., Lamark T., Brech A., Bruun J.A., Outzen H., et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 2007, 282:24131-24145.
49. Van Humbeeck C., Cornelissen T., Hofkens H., Mandemakers W., Gevaert K., De Strooper B., et al. Parkin interacts with Ambra1 to induce mitophagy. J Neurosci Off J Soc Neurosci 2011, 31:10249-10261.
50. Kubli D.A., Zhang X., Lee Y., Hanna R.A., Quinsay M.N., Nguyen C.K., et al. Parkin protein deficiency exacerbates cardiac injury and reduces survival following myocardial infarction. J Biol Chem 2013, 288:915-926.
51. Piquereau J., Godin R., Deschenes S., Bessi V.L., Mofarrahi M., Hussain S.N., et al. Protective role of PARK2/Parkin in sepsis-induced cardiac contractile and mitochondrial dysfunction. Autophagy 2013, 9:1837-1851.
52. Huang C., Andres A.M., Ratliff E.P., Hernandez G., Lee P., Gottlieb R.A. Preconditioning involves selective mitophagy mediated by Parkin and p62/SQSTM1. PLoS ONE 2011, 6:e20975.
53. Siddall H.K., Yellon D.M., Ong S.B., Mukherjee U.A., Burke N., Hall A.R., et al. Loss of PINK1 increases the heart's vulnerability to ischemia-reperfusion injury. PLoS ONE 2013, 8:e62400.
54. Billia F., Hauck L., Konecny F., Rao V., Shen J., Mak T.W. PTEN-inducible kinase 1 (PINK1)/Park6 is indispensable for normal heart function. Proc Natl Acad Sci U S A 2011, 108:9572-9577.
55. Chu C.T., Ji J., Dagda R.K., Jiang J.F., Tyurina Y.Y., Kapralov A.A., et al. Cardiolipin externalization to the outer mitochondrial membrane acts as an elimination signal for mitophagy in neuronal cells. Nat Cell Biol 2013, 15:1197-U168.
56. Liu L., Feng D., Chen G., Chen M., Zheng Q., Song P., et al. Mitochondrial outer-membrane protein FUNDC1 mediates hypoxia-induced mitophagy in mammalian cells. Nat Cell Biol 2012, 14:177-185.
57. Novak I., Kirkin V., McEwan D.G., Zhang J., Wild P., Rozenknop A., et al. Nix is a selective autophagy receptor for mitochondrial clearance. EMBO Rep 2010, 11:45-51.
58. Hanna R.A., Quinsay M.N., Orogo A.M., Giang K., Rikka S., Gustafsson A.B. Microtubule-associated protein 1 light chain 3 (LC3) interacts with BNIP3 protein to selectively remove endoplasmic reticulum and mitochondria via autophagy. J Biol Chem 2012, 287:19094-19104.
59. Schwarten M., Mohrluder J., Ma P.X., Stoldt M., Thielmann Y., Stangler T., et al. Nix directly binds to GABARAP A possible crosstalk between apoptosis and autophagy. Autophagy 2009, 5:690-698.
60. Ding W.X., Ni H.M., Li M., Liao Y., Chen X.Y., Stolz D.B., et al. Nix is critical to two distinct phases of mitophagy, reactive oxygen species-mediated autophagy induction and parkin-ubiquitin-p62-mediated mitochondrial priming. J Biol Chem 2010, 285:27879-27890.
61. Lee Y., Lee H.Y., Hanna R.A., Gustafsson A.B. Mitochondrial autophagy by Bnip3 involves Drp1-mediated mitochondrial fission and recruitment of Parkin in cardiac myocytes. Am J Physiol Heart Circ Physiol 2011, 301:H1924-H1931.
62. Dorn G.W. Mitochondrial pruning by Nix and BNIP3: an essential function for cardiac-expressed death factors. J Cardiovasc Transl Res 2010, 3:374-383.
63. Zhu H., Tannous P., Johnstone J.L., Kong Y., Shelton J.M., Richardson J.A., et al. Cardiac autophagy is a maladaptive response to hemodynamic stress. J Clin Invest 2007, 117:1782-1793.
64. Matsui Y., Takagi H., Qu X., Abdellatif M., Sakoda H., Asano T., et al. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ Res 2007, 100:914-922.
65. Chan D.C. Fusion and fission: interlinked processes critical for mitochondrial health. Annu Rev Genet 2012, 46:265-287.
66. Chen H., Detmer S.A., Ewald A.J., Griffin E.E., Fraser S.E., Chan D.C. Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol 2003, 160:189-200.
67. Chen Y., Liu Y.Q., Dorn G.W. Mitochondrial fusion is essential for organelle function and cardiac homeostasis. Circ Res 2011, 109:1327-U36.
68. Papanicolaou K.N., Kikuchi R., Ngoh G.A., Coughlan K.A., Dominguez I., Stanley W.C., et al. Mitofusins 1 and 2 are essential for postnatal metabolic remodeling in heart. Circ Res 2012, 111:1012-1026.
69. Gomes L.C., Di Benedetto G., Scorrano L. During autophagy mitochondria elongate, are spared from degradation and sustain cell viability. Nat Cell Biol 2011, 13:589-598.
70. Bhandari P., Song M., Chen Y., Burelle Y., Dorn G.W. Mitochondrial contagion induced by Parkin deficiency in Drosophila hearts and its containment by suppressing mitofusin. Circ Res 2014, 114:257-265.
71. Samant S.A., Zhang H.J., Hong Z., Pillai V.B., Sundaresan N.R., Wolfgeher D., et al. SIRT3 deacetylates and activates OPA1 to regulate mitochondrial dynamics during stress. Mol Cell Biol 2014, 34:807-819.
72. Chen L., Liu T., Tran A., Lu X., Tomilov A.A., Davies V., et al. OPA1 mutation and late-onset cardiomyopathy: mitochondrial dysfunction and mtDNA instability. J Am Heart Assoc 2012, 1:e003012.
73. Smirnova E., Griparic L., Shurland D.L., van der Bliek A.M. Dynamin-related protein Drp1 is required for mitochondrial division in mammalian cells. Mol Biol Cell 2001, 12:2245-2256.
74. Twig G., Elorza A., Molina A.J., Mohamed H., Wikstrom J.D., Walzer G., et al. Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J 2008, 27:433-446.
75. Sharp W.W., Fang Y.H., Han M., Zhang H.J., Hong Z., Banathy A., et al. Dynamin-related protein 1 (Drp1)-mediated diastolic dysfunction in myocardial ischemia-reperfusion injury: therapeutic benefits of Drp1 inhibition to reduce mitochondrial fission. FASEB J 2014, 28:316-326.
76. Ong S.B., Subrayan S., Lim S.Y., Yellon D.M., Davidson S.M., Hausenloy D.J. Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury. Circulation 2010, 121:2012-2022.
77. Lyamzaev K.G., Nepryakhina O.K., Saprunova V.B., Bakeeva L.E., Pletjushkina O.Y., Chernyak B.V., et al. Novel mechanism of elimination of malfunctioning mitochondria (mitoptosis): formation of mitoptotic bodies and extrusion of mitochondrial material from the cell. Biochim Biophys Acta 2008, 1777:817-825.
78. Nakajima A., Kurihara H., Yagita H., Okumura K., Nakano H. Mitochondrial extrusion through the cytoplasmic vacuoles during cell death. J Biol Chem 2008, 283:24128-24135.
79. Bisharyan Y., Clark T.G. Calcium-dependent mitochondrial extrusion in ciliated protozoa. Mitochondrion 2011, 11:909-918.
80. Thomas R.L., Roberts D.J., Kubli D.A., Lee Y., Quinsay M.N., Owens J.B., et al. Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure. Genes Dev 2013, 27:1365-1377.
81. Marin-Garcia J., Goldenthal M.J. Understanding the impact of mitochondrial defects in cardiovascular disease: a review. J Card Fail 2002, 8:347-361.
82. Kujoth G.C., Hiona A., Pugh T.D., Someya S., Panzer K., Wohlgemuth S.E., et al. Mitochondrial DNA mutations, oxidative stress, and apoptosis in mammalian aging. Science 2005, 309:481-484.
83. Wang X., Robbins J. Proteasomal and lysosomal protein degradation and heart disease. J Mol Cell Cardiol 2014, 71:c:16-c:24.
84. Gomes A.V., Zong C., Ping P. Protein degradation by the 26S proteasome system in the normal and stressed myocardium. Antioxid Redox Signal 2006, 8:1677-1691.
85. Razeghi P., Sharma S., Ying J., Li Y.P., Stepkowski S., Reid M.B., et al. Atrophic remodeling of the heart in vivo simultaneously activates pathways of protein synthesis and degradation. Circulation 2003, 108:2536-2541.
86. Depre C., Wang Q., Yan L., Hedhli N., Peter P., Chen L., et al. Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy. Circulation 2006, 114:1821-1828.
87. Kumarapeli A.R., Horak K.M., Glasford J.W., Li J., Chen Q., Liu J., et al. A novel transgenic mouse model reveals deregulation of the ubiquitin-proteasome system in the heart by doxorubicin. FASEB J 2005, 19:2051-2053.
88. Plun-Favreau H., Burchell V.S., Holmstrom K.M., Yao Z., Deas E., Cain K., et al. HtrA2 deficiency causes mitochondrial uncoupling through the F(1)F(0)-ATP synthase and consequent ATP depletion. Cell Death Dis 2012, 3:e335.
89. Bota D.A., Van Remmen H., Davies K.J. Modulation of Lon protease activity and aconitase turnover during aging and oxidative stress. FEBS Lett 2002, 532:103-106.
90. Delaval E., Perichon M., Friguet B. Age-related impairment of mitochondrial matrix aconitase and ATP-stimulated protease in rat liver and heart. Eur J Biochem 2004, 271:4559-4564.
91. Hoshino A., Okawa Y., Ariyoshi M., Kaimoto S., Uchihashi M., Fukai K., et al. Oxidative posttranslational modifications develop LONP1 dysfunction in pressure overload heart failure. Circ Heart Fail 2014, 7:500-509.
92. Cuervo A.M. Autophagy and aging: keeping that old broom working. Trends Genet 2008, 24:604-612.
93. Komatsu M., Waguri S., Koike M., Sou Y.S., Ueno T., Hara T., et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 2007, 131:1149-1163.
94. Singh R., Kaushik S., Wang Y., Xiang Y., Novak I., Komatsu M., et al. Autophagy regulates lipid metabolism. Nature 2009, 458:1131-1135.
95. Nakai A., Yamaguchi O., Takeda T., Higuchi Y., Hikoso S., Taniike M., et al. The role of autophagy in cardiomyocytes in the basal state and in response to hemodynamic stress. Nat Med 2007, 13:619-624.
96. Hartleben B., Godel M., Meyer-Schwesinger C., Liu S., Ulrich T., Kobler S., et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest 2010, 120:1084-1096.
97. Colman R.J., Anderson R.M., Johnson S.C., Kastman E.K., Kosmatka K.J., Beasley T.M., et al. Caloric restriction delays disease onset and mortality in rhesus monkeys. Science 2009, 325:201-204.
98. Omodei D., Fontana L. Calorie restriction and prevention of age-associated chronic disease. FEBS Lett 2011, 585:1537-1542.
99. Hoshino A., Mita Y., Okawa Y., Ariyoshi M., Iwai-Kanai E., Ueyama T., et al. Cytosolic p53 inhibits Parkin-mediated mitophagy and promotes mitochondrial dysfunction in the mouse heart. Nat Commun 2013, 4:2308.
100. Rana A., Rera M., Walker D.W. Parkin overexpression during aging reduces proteotoxicity, alters mitochondrial dynamics, and extends lifespan. Proc Natl Acad Sci U S A 2013, 110:8638-8643.
101. Kubli D.A., Quinsay M.N., Gustafsson A.B. Parkin deficiency results in accumulation of abnormal mitochondria in aging myocytes. Commun Integr Biol 2013, 6:e24511.